Antibody Drug Conjugates Market: Global Analysis & Forecasts to 2019-2026: Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc

Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells.

Conventional chemotherapy is intended to eradicate fast-growing tumor cells. However, it can also damage healthy proliferating cells, which produces undesirable side effects. In contrast, ADC is designed to upsurge the efficacy of treatment and decrease the systemic toxicity.

For More Info and For a Sample: https://www.worldwidemarketreports.com/sample/245391

Many companies are actively developing antibody-drug conjugates, majorly in U.S. and Europe. It has been estimated that 70% to 80% of ADC manufacturing is outsourced. Development of ADCs is quite challenging and only a few Contract Manufacturing Organizations (CMOs) have the competency to develop them. Hence, the market remains open for entry of new players who can overcome the manufacturing challenges.

It has been estimated that cleavable linkers will witness the fastest growth over the forecast period owing to the factors, such as wide usage of these linkers and maximum number of products in the pipeline. Furthermore, in 2017 two new Pfizer’s products-Besponsa and Mylotarg, were approved for usage in developed regions and both contain cleavable linkers.

In 2017, North America was the largest revenue generating region, followed by Europe. The major factor attributing for their continued dominance includes the presence of significant market players, such as Seattle Genetics, Roche, Pfizer, and AbbVie. North America is the most well-established market in terms of the usage of ADCs coupled with well-established healthcare infrastructure, and patient awareness.

North America is projected to witness the fastest growth over the forecast period as most of the ADCs currently in pipeline are being developed in U.S. Also, the U.S. Food and Drug Administration (FDA) is one of the first regulatory bodies to approve ADC in U.S. Hence, these factors are likely to boost market growth in the region over the forecast period.

Major Players operating in market includes: Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals among others

Key Reasons to Purchase:
1) To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
2) Assess the production processes, major issues, and solutions to mitigate the development risk.
3) To understand the most affecting driving and restraining forces in the Antibody Drug Conjugates (Adc) market and its impact in the global market.
4) Learn about the Antibody Drug Conjugates (Adc) market strategies that are being adopted by leading respective organizations.
5) To understand the future outlook and prospects for the market during years 2019-2026.

In the end, Antibody Drug Conjugates (Adc) market report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

Place an Inquire before Purchase: https://www.worldwidemarketreports.com/quiry/245391

*If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents
1. Research Objective and Assumptions
2. Market Preview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Antibody Drug Conjugates (ADC) Market, By Product Type, 2019- 2026 (US$ Million & KT & KT)
5. Global Antibody Drug Conjugates (ADC) Market, By Region, 2019- 2026 (US$ Million & KT)
6. Competitive Landscape
7. Section

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Email:sales@worldwidemarketreports.com

This release was published on openPR.